Monoamine oxidase inhibition in cigarette smokers: From preclinical studies to tobacco product regulation

Monoamine oxidase inhibition in cigarette smokers: From preclinical studies to tobacco product regulation

Monoamine oxidase (MAO) activity is reduced in cigarette smokers and this may promote the reinforcing actions of nicotine, thereby enhancing the addictive properties of cigarettes. At present, it is unclear how cigarette smoking leads to MAO inhibition, but preclinical studies in rodents show that M...

Full description

Bibliographic Details
Main Authors:	Alan F. Sved, Jillian J. Weeks, Anthony A. Grace, Tracy T. Smith, Eric C. Donny
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Neuroscience
Subjects:	nicotine monoamine oxidase (MAO) cigarette addiction tobacco schizophrenia
Online Access:	https://www.frontiersin.org/articles/10.3389/fnins.2022.886496/full

Similar Items

Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma
by: Narayan D. Chaurasiya, et al.
Published: (2022-07-01)

β-Carboline Alkaloids in Soy Sauce and Inhibition of Monoamine Oxidase (MAO)
by: Tomás Herraiz
Published: (2023-03-01)

Synthesis and Monoamine Oxidase Inhibition Properties of 4-(2-Methyloxazol-4-yl)benzenesulfonamide
by: Anton A. Shetnev, et al.
Published: (2024-03-01)

Editorial: The role of monoamine oxidase inhibition in smokers: Toward understanding their potential effects in reinforcing nicotine dependence
by: Penelope Truman
Published: (2022-11-01)

Catalysis & inhibition issues associated with Monoamine Oxidase (MAO). How unusually low α-C-H bond dissociation energies may open the door to single electron transfer
by: Jonathan Sánchez González, et al.
Published: (2023-12-01)

Monoamine Oxidase (MAO) Is Expressed at the Level of Mitral Valve with Severe Regurgitation in Hypertrophic Obstructive Cardiomyopathy: A Case Report
by: Ana Lascu, et al.
Published: (2022-12-01)

Role of Monoamine Oxidase Activity in Alzheimer’s Disease: An Insight into the Therapeutic Potential of Inhibitors
by: Tapan Behl, et al.
Published: (2021-06-01)

Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies
by: Makoto Naoi, et al.
Published: (2022-09-01)

The inhibition of monoamine oxidase by harmine derivatives
by: Theo Myburg, et al.
Published: (2022-01-01)

Microbial Metabolite Urolithin B Inhibits Recombinant Human Monoamine Oxidase A Enzyme
by: Rajbir Singh, et al.
Published: (2020-06-01)

Ageing and Neurodegeneration – The Role of Neurotransmitters’ Activity
by: Bonka Lozanska, et al.
Published: (2022-12-01)

A comparison of electrocardiographic parameters in e-cigarette users, conventional cigarette smokers, and non-smokers
by: Heba Ammar, et al.
Published: (2024-01-01)

Colorimetric dopamine detection based on immobilized monoamine oxidase through silver nanoparticles
by: Shin, Gounhanul, et al.
Published: (2023)

Comparison of monoamine oxidase and selected heavy metal levels in the blood and the workplace among e-waste sorting workers in Ubon Ratchathani Province, Thailand
by: Kornwika Harasarn, et al.
Published: (2022-12-01)

Computational Insights into β-Carboline Inhibition of Monoamine Oxidase A
by: Alja Prah, et al.
Published: (2022-10-01)

Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development
by: Reem Aljanabi, et al.
Published: (2021-10-01)

Methylxanthines Inhibit Primary Amine Oxidase and Monoamine Oxidase Activities of Human Adipose Tissue
by: Wiem Haj Ahmed, et al.
Published: (2020-04-01)

Association between Single Nucleotide Polymorphisms in Monoamine Oxidase and the Severity of Addiction to Betel Quid
by: Chung-Chieh Hung, et al.
Published: (2024-01-01)

Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors
by: Jong Min Oh, et al.
Published: (2020-05-01)

Allelic Diversity of VNTR Polymorphism in Monoamine Oxidase A (MAOA) Gene in Young Women and Men in Mashhad, Iran
by: Sedigheh Sadat Hojjati, et al.
Published: (2020-02-01)

Selective Interactions of <i>O</i>-Methylated Flavonoid Natural Products with Human Monoamine Oxidase-A and -B
by: Narayan D. Chaurasiya, et al.
Published: (2020-11-01)

Coumarin-Based Dual Inhibitors of Human Carbonic Anhydrases and Monoamine Oxidases Featuring Amino Acyl and (<i>Pseudo</i>)-Dipeptidyl Appendages: In Vitro and Computational Studies
by: Mariangela Agamennone, et al.
Published: (2022-11-01)

Commentary: Harmane potentiates nicotine reinforcement through MAO-A inhibition at the dose related to cigarette smoking
by: Penelope Truman
Published: (2023-02-01)

Green Oxidation of Amines by a Novel Cold-Adapted Monoamine Oxidase MAO P3 from Psychrophilic Fungi <i>Pseudogymnoascus</i> sp. P3
by: Iga Jodłowska, et al.
Published: (2021-10-01)

Development of morpholine ring-bearing halogenated α,β-unsaturated ketones as selective monoamine oxidase-B inhibitors
by: Jiseong Lee, et al.
Published: (2024-01-01)

Dual Targeting Ligands—Histamine H<sub>3</sub> Receptor Ligands with Monoamine Oxidase B Inhibitory Activity—In Vitro and In Vivo Evaluation
by: Dorota Łażewska, et al.
Published: (2022-10-01)

Enantioselective Interactions of Anti-Infective 8-Aminoquinoline Therapeutics with Human Monoamine Oxidases A and B
by: Narayan D. Chaurasiya, et al.
Published: (2021-04-01)

Inhibition of monoamine oxidases by benzimidazole chalcone derivatives
by: Athulya Krishna, et al.
Published: (2023-06-01)

Non-nicotine constituents in cigarette smoke extract enhance nicotine addiction through monoamine oxidase A inhibition
by: Guanglin Liu, et al.
Published: (2022-11-01)

Inhibitions of monoamine oxidases by ferulic acid hydrazide derivatives: synthesis, biochemistry, and computational evaluation
by: Arshida Thottile Peedikayil, et al.
Published: (2023-10-01)

Monoamine Oxidase-Dependent Pro-Survival Signaling in Diabetic Hearts Is Mediated by miRNAs
by: Stefano Cagnin, et al.
Published: (2022-08-01)

Development of Halogenated Pyrazolines as Selective Monoamine Oxidase-B Inhibitors: Deciphering via Molecular Dynamics Approach
by: Aathira Sujathan Nair, et al.
Published: (2021-05-01)

Monoamine Oxidase Inhibitors Prevent Glucose-Dependent Energy Production, Proliferation and Migration of Bladder Carcinoma Cells
by: Jessica Resta, et al.
Published: (2022-10-01)

Design, synthesis, molecular modelling and in vitro screening of monoamine oxidase inhibitory activities of novel quinazolyl hydrazine derivatives
by: Adel Amer, et al.
Published: (2020-04-01)

Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities
by: Zofia Chrienova, et al.
Published: (2022-12-01)

In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease
by: Huang ST, et al.
Published: (2024-01-01)

Evaluation of functional aerobic exercise capacity among chronic e-cigarette users compared to combustible cigarette smokers and non-smokers: a comparative study
by: Heba Ammar, et al.
Published: (2023-10-01)

Monoamine oxidase A: An emerging therapeutic target in prostate cancer
by: Chia-Hui Chen, et al.
Published: (2023-02-01)

Different Effects of SSRIs, Bupropion, and Trazodone on Mitochondrial Functions and Monoamine Oxidase Isoform Activity
by: Matej Ľupták, et al.
Published: (2023-06-01)

Phytoestrogen Coumestrol Selectively Inhibits Monoamine Oxidase-A and Amyloid β Self-Aggregation
by: Su Hui Seong, et al.
Published: (2022-09-01)